Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
J Pediatr. 2010 Mar;156(3):466-71. doi: 10.1016/j.jpeds.2009.09.071. Epub 2009 Nov 14.
To determine whether age at premature thelarche (PT) onset affects the clinical characteristics, course, and risk of progression to precocious puberty (PP).
Data regarding course of growth and puberty were retrieved from the medical files of 139 girls with PT followed up from 1995 to 2005. Analysis was based on age at PT appearance (birth, 1-24 months, and 2-8 years); course was categorized as regressive, persistent, progressive, or cyclic.
At diagnosis, height standard deviation score, bone age-chronological age ratio, and hormonal values were comparable in the 3 age groups. PT regressed in 50.8%, persisted in 36.3%, progressed in 3.2% and had a cyclic course in 9.7%. A progressive or cyclic course was significantly more prevalent among girls presenting after 2 years (52.6%) compared with girls presenting at birth (13.0%) or at 1 to 24 months (3.8%) (P < .001). PP occurred in 13% irrespective of age at PT presentation or clinical course.
Clinical and anthropometric characteristics at admission and risk of PP were similar in all girls with PT, regardless of age at onset. There are currently no clinical or laboratory tests that can predict the risk of progression to PP at presentation.
确定性早熟(PT)起始年龄是否会影响临床特征、病程以及向性早熟(PP)进展的风险。
从 1995 年至 2005 年随访的 139 例 PT 女孩的病历中检索到关于生长和青春期过程的数据。分析基于 PT 出现的年龄(出生时、1-24 个月和 2-8 岁);病程分为退行性、持续性、进行性或周期性。
在诊断时,身高标准差评分、骨龄-年龄比和激素值在 3 个年龄组中是可比的。PT 中有 50.8%消退,36.3%持续,3.2%进展,9.7%呈周期性。与出生时(13.0%)或 1 至 24 个月(3.8%)就诊的女孩相比,2 岁后就诊的女孩(52.6%)进展或周期性病程更为常见(P <.001)。无论 PT 发病年龄或临床病程如何,PP 的发生率均为 13%。
无论发病年龄如何,所有 PT 女孩入院时的临床和人体测量特征以及发生 PP 的风险均相似。目前尚无临床或实验室检查可在就诊时预测进展为 PP 的风险。